Nemeroff CB
Dell Medical School, University of Texas at Austin, Austin, TX, USA.
ArticlePsychedelics
Correction: Psychedelic therapeutics in psychiatric conditions.
ArticlePsychedelics
Trends in the psychedelic renaissance: applying artificial intelligence to measure media portrayal of psychedelic drugs in the 21st century.
ArticleMDMA
Psychedelic therapeutics in psychiatric conditions.
ArticlePsilocybin
There's More Than One Way to Bring Health Back: Divergent Effects of Psilocybin and Escitalopram Treatment on Emotional Brain Function in Depression.
ArticlePsilocybin
Psilocybin: From Psychiatric Pariah to Perceived Panacea.
ArticleMDMA
MDMA and MDMA-Assisted Therapy.
ArticleMDMA
Novel Pharmacologic and Other Somatic Treatment Approaches for Posttraumatic Stress Disorder in Adults: State of the Evidence.
ArticlePsychedelics
The mechanistic divide in psychedelic neuroscience: An unbridgeable gap?
ArticlePsilocybin
Psychological Support for Psilocybin Treatment: Reply to Letters on Our Commentary.
ArticleKetamine
Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions.
ArticlePsilocybin
A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability.
ArticlePsilocybin
Psychedelics and Psychedelic-Assisted Psychotherapy.
ArticlePsilocybin